World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
43510
World Ranking
11103
National Ranking
1050

Michel P Coleman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Michel P Coleman sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 357 publications — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Michel P Coleman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Michel P Coleman sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Michel P Coleman is affiliated with the London School of Hygiene & Tropical Medicine in the United Kingdom. Their research primarily focuses on the field of medicine with a strong emphasis on oncology. The subfields of study include oncology, economics and econometrics, general health professions, genetics, and pediatrics, perinatology, and child health.

The scientist's work covers several main topics related to cancer and healthcare, including:

  • Global Cancer Incidence and Screening
  • Economic and Financial Impacts of Cancer
  • Colorectal Cancer Screening and Detection
  • Childhood Cancer Survivors' Quality of Life
  • Glioma Diagnosis and Treatment
  • Cutaneous Melanoma Detection and Management
  • COVID-19 and healthcare impacts

Michel P Coleman's recent notable publications include:

  • Sustainable care for children with cancer: a Lancet Oncology Commission (2020, The Lancet Oncology)
  • Trends in short-term survival from distant-stage cutaneous melanoma in the United States, 2001-2013 (CONCORD-3) (2020, JNCI Cancer Spectrum)
  • Does the morphology of cutaneous melanoma help to explain the international differences in survival? Results from 1,578,482 adults diagnosed during 2000-2014 in 59 countries (CONCORD-3) (2022, British Journal of Dermatology)
  • Occupation and COVID-19 mortality in England: a national linked data study of 14.3 million adults (2021, Occupational and Environmental Medicine)
  • Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial (2020, Annals of Oncology)

Frequent co-authors who have collaborated with Michel P Coleman are:

  • Claudia Allemani
  • V Di Carlo
  • M Matz
  • Fabio Girardi
  • Charles Stiller

The main publication venues where Michel P Coleman's research appears include:

  • Neuro-Oncology
  • Cancer Epidemiology
  • The Lancet Oncology
  • JNCI Cancer Spectrum
  • Journal of Epidemiology & Community Health

Best Publications

  • Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

    Claudia Allemani;Tomohiro Matsuda;Veronica Di Carlo;Rhea Harewood

  • Global surveillance of cancer survival 1995–2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

    Claudia Allemani;Hannah K Weir;Helena Carreira;Rhea Harewood

  • Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE--5-a population-based study

    Roberta De Angelis;Milena Sant;Michel P Coleman;Silvia Francisci

  • Cancer survival in five continents: a worldwide population-based study (CONCORD)

    Michel P. Coleman;Manuela Quaresma;Franco Berrino;Jean Michel Lutz

  • An international association between Helicobacter pylori infection and gastric cancer

    D Forman;M Coleman;Gui De Backer;J Eider

  • Trends in cancer incidence and mortality

    M P Coleman;J Estève;P Damiecki;A Arslan

  • Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data

    MP Coleman;D Forman;H Bryant;J Butler

  • The global burden of women's cancers: a grand challenge in global health

    Ophira M Ginsburg;Ophira M Ginsburg;Freddie Bray;Michel P Coleman;Verna Dnk Vanderpuye

  • Cancer survival in China, 2003–2005: A population‐based study

    Hongmei Zeng;Rongshou Zheng;Yuming Guo;Siwei Zhang

  • Origins of socio-economic inequalities in cancer survival: a review

    L. M. Woods;B. Rachet;M. P. Coleman

  • EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century.

    M.P. Coleman;G. Gatta;A. Verdecchia;J. Estève

  • Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004–2007

    Sarah Walters;Camille Maringe;Michel P Coleman;Michael D Peake;Michael D Peake

  • EPIDEMIOLOGY OF, AND RISK-FACTORS FOR, HELICOBACTER-PYLORI INFECTION AMONG 3194 ASYMPTOMATIC SUBJECTS IN 17 POPULATIONS.

    D Forman;Gui De Backer;J Elder;H Moller

  • 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971–2011: a population-based study

    Manuela Quaresma;Michel P Coleman;Bernard Rachet

  • Radiation dose and second cancer risk in patients treated for cancer of the cervix.

    John D. Boice;Goran Engholm;Ruth Kleinerman;Maria Blettner

  • Second cancers following radiation treatment for cervical cancer. An international collaboration among cancer registries

    Jr Jd Boice;NE Day;A Andersen;LA Brinton

  • Excess mortality in England and Wales, and in Greater London, during the 1995 heatwave.

    C Rooney;A J McMichael;R S Kovats;M P Coleman

  • Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001

    M P Coleman;B Rachet;L M Woods;E Mitry

  • Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe

    Milena Sant;Claudia Allemani;Riccardo Capocaccia;Timo Hakulinen

  • Childhood cancer burden: a review of global estimates.

    Nickhill Bhakta;Lisa M Force;Claudia Allemani;Rifat Atun

Frequent Co-Authors

Franco Berrino
Franco Berrino Fondazione IRCCS Istituto Nazionale dei Tumori
Michael A. Quinn
Michael A. Quinn International Gynaecological Cancer Society
Hans H. Storm
Hans H. Storm Danish Cancer Society
Timo Hakulinen
Timo Hakulinen University of Helsinki
Gemma Gatta
Gemma Gatta Fondazione Lombardia per l’Ambiente
David Forman
David Forman International Agency For Research On Cancer
Gerda Engholm
Gerda Engholm National Research Foundation
Charles A. Stiller
Charles A. Stiller Public Health England
Henrik Møller
Henrik Møller King's College London
Hermann Brenner
Hermann Brenner German Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring careers in healthcare goes beyond becoming a physician. Many students begin with the nursing path, and affordable options are available. For those looking to start their nursing career, check out the cheapest bsn programs that provide a cost-effective route to a Bachelor of Science in Nursing.

If you already hold a non-nursing bachelor’s degree and want to move directly into advanced nursing roles, consider direct entry online msn programs for a quicker transition into the nursing field.

For those seeking an entry-level pathway, many turn to adn programs, which are generally more accessible and can be a stepping stone to further studies.

Not all health careers require direct patient care. If you are interested in administrative roles, you can find reputable medical coding and billing classes online with financial aid. These programs can open doors to vital roles in healthcare management and support.

Best Scientists Citing Michel P Coleman

Trending Scientists

Recently Published Articles